Cargando…

Technique, outcome and changes in prostate dimensions in patients with urinary retention managed by aquablation

PURPOSE: This study aimed to investigate the functional and urodynamic outcome of Aquablation in patients with acute urinary retention (AUR) on catheters. METHODS: Men aged 50–70 who failed medical treatment of BPO with AUR failing to wean off urethral catheter were recruited to undergo Aquablation....

Descripción completa

Detalles Bibliográficos
Autores principales: Yee, Chi-Hang, Tang, Sui-Fan, Yuen, Steffi Kar-Kei, Chan, Chi-Kwok, Teoh, Jeremy Y. C., Chiu, Peter K. F., Ng, Chi-Fai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Netherlands 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9136199/
https://www.ncbi.nlm.nih.gov/pubmed/35622268
http://dx.doi.org/10.1007/s11255-022-03244-y
_version_ 1784714125596688384
author Yee, Chi-Hang
Tang, Sui-Fan
Yuen, Steffi Kar-Kei
Chan, Chi-Kwok
Teoh, Jeremy Y. C.
Chiu, Peter K. F.
Ng, Chi-Fai
author_facet Yee, Chi-Hang
Tang, Sui-Fan
Yuen, Steffi Kar-Kei
Chan, Chi-Kwok
Teoh, Jeremy Y. C.
Chiu, Peter K. F.
Ng, Chi-Fai
author_sort Yee, Chi-Hang
collection PubMed
description PURPOSE: This study aimed to investigate the functional and urodynamic outcome of Aquablation in patients with acute urinary retention (AUR) on catheters. METHODS: Men aged 50–70 who failed medical treatment of BPO with AUR failing to wean off urethral catheter were recruited to undergo Aquablation. Individuals were assessed pre-operatively and at 3 and 6 months after surgery. The primary outcome was defined by the success rate of weaning off catheter. Secondary outcomes were measured by a change in prostate size, symptom scores and urodynamic parameters. RESULTS: Twenty patients underwent Aquablation between June 2019 and September 2020. Mean duration of the urethral catheter in-situ was 5.9 ± 4.9 weeks and mean prostate size of the cohort pre-operatively was 60.8 ± 15.8 cc. A second pass Aqaublation treatment was performed in 14 patients. Five patients failed to wean off the catheter on the first attempt after surgery, requiring another attempt 1 week later which were all successful. At 3 months after the operation, a significant reduction in prostate volume was observed (60.8 ± 15.8 cc vs 24.9 ± 10.3 cc, p < 0.001). No change in international index of erectile function (IIEF) was found (baseline: 16.1 ± 5.8; 3-month: 14.9 ± 6.4; p = 0.953). Mean bladder outlet obstruction index was 14.2 ± 23.0 at 6 months upon urodynamic assessment with 75% of patients had a resolution of detrusor overactivity. Reduction in prostate length was found to be more significant than a reduction in width and height after Aquablation (R = 0.693, p = 0.039). CONCLUSION: From the early data of a single centre, Aquablation was shown to provide a consistent improvement in symptoms, uroflowmetry and urodynamic parameters in patient with a urethral catheter. Results from our study suggest that improvement from Aquablation is reproducible in patients with AUR. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s11255-022-03244-y.
format Online
Article
Text
id pubmed-9136199
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Springer Netherlands
record_format MEDLINE/PubMed
spelling pubmed-91361992022-06-02 Technique, outcome and changes in prostate dimensions in patients with urinary retention managed by aquablation Yee, Chi-Hang Tang, Sui-Fan Yuen, Steffi Kar-Kei Chan, Chi-Kwok Teoh, Jeremy Y. C. Chiu, Peter K. F. Ng, Chi-Fai Int Urol Nephrol Urology - Original Paper PURPOSE: This study aimed to investigate the functional and urodynamic outcome of Aquablation in patients with acute urinary retention (AUR) on catheters. METHODS: Men aged 50–70 who failed medical treatment of BPO with AUR failing to wean off urethral catheter were recruited to undergo Aquablation. Individuals were assessed pre-operatively and at 3 and 6 months after surgery. The primary outcome was defined by the success rate of weaning off catheter. Secondary outcomes were measured by a change in prostate size, symptom scores and urodynamic parameters. RESULTS: Twenty patients underwent Aquablation between June 2019 and September 2020. Mean duration of the urethral catheter in-situ was 5.9 ± 4.9 weeks and mean prostate size of the cohort pre-operatively was 60.8 ± 15.8 cc. A second pass Aqaublation treatment was performed in 14 patients. Five patients failed to wean off the catheter on the first attempt after surgery, requiring another attempt 1 week later which were all successful. At 3 months after the operation, a significant reduction in prostate volume was observed (60.8 ± 15.8 cc vs 24.9 ± 10.3 cc, p < 0.001). No change in international index of erectile function (IIEF) was found (baseline: 16.1 ± 5.8; 3-month: 14.9 ± 6.4; p = 0.953). Mean bladder outlet obstruction index was 14.2 ± 23.0 at 6 months upon urodynamic assessment with 75% of patients had a resolution of detrusor overactivity. Reduction in prostate length was found to be more significant than a reduction in width and height after Aquablation (R = 0.693, p = 0.039). CONCLUSION: From the early data of a single centre, Aquablation was shown to provide a consistent improvement in symptoms, uroflowmetry and urodynamic parameters in patient with a urethral catheter. Results from our study suggest that improvement from Aquablation is reproducible in patients with AUR. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s11255-022-03244-y. Springer Netherlands 2022-05-27 2022 /pmc/articles/PMC9136199/ /pubmed/35622268 http://dx.doi.org/10.1007/s11255-022-03244-y Text en © The Author(s), under exclusive licence to Springer Nature B.V. 2022 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Urology - Original Paper
Yee, Chi-Hang
Tang, Sui-Fan
Yuen, Steffi Kar-Kei
Chan, Chi-Kwok
Teoh, Jeremy Y. C.
Chiu, Peter K. F.
Ng, Chi-Fai
Technique, outcome and changes in prostate dimensions in patients with urinary retention managed by aquablation
title Technique, outcome and changes in prostate dimensions in patients with urinary retention managed by aquablation
title_full Technique, outcome and changes in prostate dimensions in patients with urinary retention managed by aquablation
title_fullStr Technique, outcome and changes in prostate dimensions in patients with urinary retention managed by aquablation
title_full_unstemmed Technique, outcome and changes in prostate dimensions in patients with urinary retention managed by aquablation
title_short Technique, outcome and changes in prostate dimensions in patients with urinary retention managed by aquablation
title_sort technique, outcome and changes in prostate dimensions in patients with urinary retention managed by aquablation
topic Urology - Original Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9136199/
https://www.ncbi.nlm.nih.gov/pubmed/35622268
http://dx.doi.org/10.1007/s11255-022-03244-y
work_keys_str_mv AT yeechihang techniqueoutcomeandchangesinprostatedimensionsinpatientswithurinaryretentionmanagedbyaquablation
AT tangsuifan techniqueoutcomeandchangesinprostatedimensionsinpatientswithurinaryretentionmanagedbyaquablation
AT yuensteffikarkei techniqueoutcomeandchangesinprostatedimensionsinpatientswithurinaryretentionmanagedbyaquablation
AT chanchikwok techniqueoutcomeandchangesinprostatedimensionsinpatientswithurinaryretentionmanagedbyaquablation
AT teohjeremyyc techniqueoutcomeandchangesinprostatedimensionsinpatientswithurinaryretentionmanagedbyaquablation
AT chiupeterkf techniqueoutcomeandchangesinprostatedimensionsinpatientswithurinaryretentionmanagedbyaquablation
AT ngchifai techniqueoutcomeandchangesinprostatedimensionsinpatientswithurinaryretentionmanagedbyaquablation